![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
https://www.globenewswire.com/news-release/2023/04/26/2654655/0/en/Press-Release-Hart-Scott-Rodino-waiting-period-expires-for-Sanofi-s-acquisition-of-Provention-Bio-Inc.html
https://www.fiercepharma.com/pharma/sanofis-29b-deal-provention-bio-hit-protracted-ftc-review-wheres-pfizer-seagen
https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13-06-00-00-2625367
https://www.prnewswire.com/news-releases/provention-bio-cancels-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call-301769842.html
https://www.prnewswire.com/news-releases/provention-bio-announces-the-grant-of-inducement-awards-301761851.html
https://www.prnewswire.com/news-releases/provention-bio-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-16-2023-301754445.html
https://www.contractpharma.com/contents/view_breaking-news/2023-02-14/provention-bio-completes-35m-equity-investment-from-sanofi-us/?widget=listSection
https://www.prnewswire.com/news-releases/provention-bio-announces-completion-of-35-million-equity-investment-from-sanofi-us-301744683.html
https://investors.proventionbio.com/2023-02-08-Provention-Bio-to-Present-at-the-SVB-Securities-Global-Biopharma-Conference
https://www.prnewswire.com/news-releases/provention-bio-announces-the-grant-of-inducement-awards-301738562.html